Sustainability & Environmental, Social and Governance Reports

Overview

The report presents the company's 2023 sustainability performance across ESG governance, healthcare access, people, environmental management and philanthropy. It highlights CNY 260.295 bn in operating revenue, 48,164 employees, 59 energy-efficiency programs, 17 green factories, and CNY 38.041 million in public welfare expenditures. The Board is identified as responsible for ESG governance, with the Audit Committee overseeing ESG matters through the governance structure. Environmental highlights include approximately CNY 135 million invested in environmental protection and a carbon-peak goal for pharmaceutical subsidiaries by 2030.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services